Alginate Antikörper
-
- Target
- Alginate
- Reaktivität
- Pseudomonas
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- ELISA
- Kreuzreaktivität
- Pseudomonas
- Immunogen
- Sodium alginate conjugated to KLH
- Klon
- 3G4-1F5
- Isotyp
- IgG1
-
-
- Applikationshinweise
- ELISA: Use at 0.5-20 μg/mL with alginate on the solid phase. Working concentrations for these antibodies are dependent on the purity and concentration of alginate in samples tested.
- Kommentare
-
Anti-Alginate Mouse Monoclonal Antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Rekonstitution
- Dilute in PBS or medium that is identical to that used in the assay system.
- Konzentration
- Lot specific
- Buffer
- 50 % Glycerol,PBS, pH 7.4, 50 % glycerol, 0.1 % sodium azide.,Phosphate Buffered Saline
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- These antibodies are stable for at least one (1) year at -20°C. Store in appropriate aliquots to avoid multiple freeze-thaw cycles.
-
- Target
- Alginate
- Substanzklasse
- Chemical
- Hintergrund
- Pulmonary infection by mucoid, alginate-producing Pseudomonas aeruginosa is the leading cause of mortality among patients suffering from cystic fibrosis. During early childhood, cystic fibrosis patients are colonized by multiple bacterial pathogens including nonmucoid P. aeruginosa. The appearance of mucoid isolates indicates progression to chronic infections. Recent evidence indicates that P. aeruginosa is most resistant to antibiotics when the infecting cells are present as a biofilm, as they appear to be in the lungs of cystic fibrosis patients.
-